The impact of repeated cost containment policies on pharmaceutical expenditure: experience in Spain

@article{MorenoTorres2010TheIO,
  title={The impact of repeated cost containment policies on pharmaceutical expenditure: experience in Spain},
  author={Iv{\'a}n Moreno-Torres and Jaume Puig-Junoy and Josep Maria Raya},
  journal={The European Journal of Health Economics},
  year={2010},
  volume={12},
  pages={563-573}
}
The growth in expenditure on the financing of pharmaceuticals is a factor that accounts for a large part of the increase in public health spending in most developed countries. In an attempt to kerb this growth, many health authorities, particularly in Europe, have introduced numerous regulatory measures that have affected the market, especially on the supply side. These measures include the system of reference pricing, the reduction of wholesale distributors’ and retailers’ markups and… CONTINUE READING